Two Sigma Advisers LP Decreases Stake in Design Therapeutics, Inc. (NASDAQ:DSGN)
Two Sigma Advisers LP lessened its stake in Design Therapeutics, Inc. (NASDAQ:DSGN – Free Report) by 23.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 233,900 shares of the company’s stock after selling 71,000 shares during the quarter. Two Sigma Advisers LP […]
Two Sigma Advisers LP lessened its stake in Design Therapeutics, Inc. (NASDAQ:DSGN – Free Report) by 23.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 233,900 shares of the company’s stock after selling 71,000 shares during the quarter. Two Sigma Advisers LP […]
